|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Musculoskeletal Imaging |
1 From the Departments of Radiology (S.F.K., C.C.H., S.H.N., Chen-Chang Lee, Chih-Chia Lee), Thoracic and Cardiovascular Surgery (M.J.H.), Neurology (T.K.L.), and Public Health and Biostatistics (M.C.C.), Chang Gung University, College of Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan; and Department of Chemistry, National Sun Yat-Sen University, Kaohsiung, Taiwan (L.L.). Received March 31, 2007; revision requested May 30; revision received June 11; accepted July 18; final version accepted September 7. S.F.K. supported by grant NSC 93-2314-B-182A-085 from the National Science Council, Taiwan. Address correspondence to S.F.K. (e-mail: sfatko{at}adm.cgmh.org.tw).
Purpose: To prospectively assess muscle metabolism in myasthenia gravis (MG) patients before and after thymectomy by using phosphorus 31 (31P) magnetic resonance (MR) spectroscopy.
Materials and Methods: With institutional review board approval and informed consent, resting and dynamic 31P MR spectroscopy were performed in 14 healthy volunteers (five men, nine women; mean age, 33 years; range, 23–48 years) and 16 MG patients (six men, 10 women; mean age, 37 years; range 18–50 years) before and after thymectomy. Patients were stratified into groups according to the modified Osserman classification: mild-MG group (classes I–IIA) and moderate-to-severe–MG group (classes IIB–IV). Variables compared among the three groups (Kruskal-Wallis test) included the inorganic phosphate (Pi)–adenosine triphosphate (ATP) (Pi/ATP) ratio, phosphocreatine (PCr)-ATP (PCr/ATP) ratio, Pi/PCr ratio, muscle pH at resting and at end-exercise 31P MR spectroscopy, rate constant for PCr recovery (kPCr), and maximum oxidative capacity (Vmax). These variables were also compared in MG patients before and after thymectomy (Wilcoxon signed rank test).
Results: There were no significant differences in resting Pi/ATP, PCr/ATP, and Pi/PCr ratios and resting muscle pH among the three groups (control group, 14; mild-MG group, nine; moderate-to-severe–MG group, seven). Comparison of the control group with the mild-MG group and comparison of the mild-MG group before thymectomy with the mild-MG group after thymectomy showed no significant differences in end-exercise Pi/ATP, PCr/ATP, and Pi/PCr ratios; end-exercise muscle pH; kPCr; and Vmax. Compared with the control and mild-MG groups, the moderate-to-severe–MG group had significantly higher end-exercise Pi/ATP and Pi/PCr ratios and significantly lower end-exercise muscle pH, kPCr, and Vmax before thymectomy (P
.001), but these values showed significant restoration to normal after thymectomy (P = .018).
Conclusion: Mild-MG group patients have muscle oxidative metabolism similar to that of healthy control subjects, whereas moderate-to-severe–MG group patients have impaired Vmax during exercise and a noticeable shift to glycolytic metabolism, but these abnormalities are reversible after thymectomy.
© RSNA, 2008
Related Article
Radiology 2008 247: 1-2.
This article has been cited by other articles:
![]() |
D. Lindquist What Can 31P MR Spectroscopy Tell Us about Muscle Disease? Radiology, April 1, 2008; 247(1): 1 - 2. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |